Melissa R Budicini

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Dna Methylation

Top Venues

Journal of virology

Pathogens (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Melissa R Budicini, Valerie J Rodriguez-Irizarry, Robert W Maples, Julie K Pfeiffer
Murine norovirus mutants adapted to replicate in human cells reveal a post-entry restriction. Journal of virology 98 (5) (2024)
Melissa R Budicini, Valerie J Rodriguez-Irizarry, Robert W Maples, Julie K Pfeiffer
Murine norovirus mutants adapted to replicate in human cells reveal a post-entry restriction. Journal of virology (2024)
Melissa R Budicini, Valerie J Rodriguez-Irizarry, Robert W Maples, Julie K Pfeiffer
Murine norovirus mutants adapted to replicate in human cells reveal a post-entry restriction. Journal of virology 98 (5) (2024)
Melissa R Budicini, Valerie J Rodriguez-Irizarry, Robert W Maples, Julie K Pfeiffer
Murine norovirus mutants adapted to replicate in human cells reveal a post-entry restriction. Journal of virology (2024)
Melissa R Budicini, Valerie J Rodriguez-Irizarry, Robert W Maples, Julie K Pfeiffer
Murine norovirus mutants adapted to replicate in human cells reveal a post-entry restriction. Journal of virology 98 (5) (2024)
Melissa R Budicini, Valerie J Rodriguez-Irizarry, Robert W Maples, Julie K Pfeiffer
Murine norovirus mutants adapted to replicate in human cells reveal a post-entry restriction. Journal of virology 98 (5) (2024)
Kristen A Johnson, Nisha Bhattarai, Melissa R Budicini, Carolyn M LaBonia, Sarah Catherine B Baker, Bernard S Gerstman, Prem P Chapagain, Robert V Stahelin
Cysteine Mutations in the Ebolavirus Matrix Protein VP40 Promote Phosphatidylserine Binding by Increasing the Flexibility of a Lipid-Binding Loop. Viruses 13 (7) (2021)
Kristen A Johnson, Rudramani Pokhrel, Melissa R Budicini, Bernard S Gerstman, Prem P Chapagain, Robert V Stahelin
A Conserved Tryptophan in the Ebola Virus Matrix Protein C-Terminal Domain Is Required for Efficient Virus-Like Particle Formation. Pathogens (Basel, Switzerland) 9 (5) (2020)